175EGP
- Active ingredient
- daclatasvir
- Strength
- 60 mg
- Form
- tablet
- Manufacturer
- european egyptian pharm. ind.
- Route
- oral.solid
Uses
Used with other antiviral agents for treatment of chronic hepatitis C infection.
Do not use if
Contraindications depend largely on the companion antiviral regimen and interacting medicines.
Side effects
Fatigue, headache, nausea, and insomnia may occur depending on combination therapy.
Warnings
Monitor for drug interactions and liver disease considerations. Use only as part of an approved regimen.
How it works
Direct-acting antiviral that inhibits the HCV NS5A protein and suppresses viral replication.
Storage
Store at room temperature.